Experience

Stibbe advises a leading pharmaceutical company

Stibbe advises a leading pharmaceutical company

Stibbe advises a leading pharmaceutical company

10.04.2013 BE law

Assisting our client in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredient and for combination products that are registered based on a well-established use.

The strategy we developed for the client consists of mixing the various types of product registration to influence pricing/reimbursement. It is essential for our client to differentiate its products from those of its competitors so that it could mitigate the impact of price cuts imposed by the authorities.

Team

Related experience

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring